These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28627677)

  • 1. Integrated analysis of the potential roles of miRNA‑mRNA networks in triple negative breast cancer.
    Zhu H; Dai M; Chen X; Chen X; Qin S; Dai S
    Mol Med Rep; 2017 Aug; 16(2):1139-1146. PubMed ID: 28627677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Physiol; 2019 Jul; 234(7):11768-11779. PubMed ID: 30488443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
    Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis.
    Qattan A; Al-Tweigeri T; Alkhayal W; Suleman K; Tulbah A; Amer S
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of miRNA and mRNA expression in the blood of patients with Alzheimer's disease.
    Wang Z; Shen L; Wang Y; Huang S
    Mol Med Rep; 2020 Aug; 22(2):1053-1062. PubMed ID: 32468026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Expression Network Analysis Identifies miRNA⁻mRNA Networks Potentially Regulating Milk Traits and Blood Metabolites.
    Ammah AA; Do DN; Bissonnette N; Gévry N; Ibeagha-Awemu EM
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
    Tian H; Chen S; Zhang C; Li M; Zheng H
    Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analyses of triple negative dysregulated transcripts compared with non-triple negative tumors and their functional and molecular interactions.
    Darbeheshti F; Rezaei N; Amoli MM; Mansoori Y; Tavakkoly Bazzaz J
    J Cell Physiol; 2019 Dec; 234(12):22386-22399. PubMed ID: 31081218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
    Yang J; Zeng Y
    Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.
    Chen C; Li Z; Yang Y; Xiang T; Song W; Liu S
    Cancer Biol Ther; 2015; 16(6):856-65. PubMed ID: 25996380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
    PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.
    Bottai G; Diao L; Baggerly KA; Paladini L; Győrffy B; Raschioni C; Pusztai L; Calin GA; Santarpia L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer.
    Naorem LD; Prakash VS; Muthaiyan M; Venkatesan A
    Int J Biol Macromol; 2020 Feb; 145():429-436. PubMed ID: 31883894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated microRNA-mRNA analysis revealing the potential roles of microRNAs in tongue squamous cell cancer.
    Zhou XL; Wu JH; Wang XJ; Guo FJ
    Mol Med Rep; 2015 Jul; 12(1):885-94. PubMed ID: 25760063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race Disparities in the Contribution of miRNA Isoforms and tRNA-Derived Fragments to Triple-Negative Breast Cancer.
    Telonis AG; Rigoutsos I
    Cancer Res; 2018 Mar; 78(5):1140-1154. PubMed ID: 29229607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.